State Street Health Care Select Sector SPDR ETF (XLV) Fund Overview
Educational signal · not a buy or sell recommendation · How to read this
Beta 0.65: the stock has moved about 35% less than the S&P 500.
For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated Mar 17, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Quick AnswerState Street Health Care Select Sector SPDR ETF (XLV) trades at $166.18. The State Street Health Care Select Sector SPDR ETF (XLV) mirrors the Health Care Select Sector Index, offering targeted exposure to the U.S. healthcare industry. Sector: Financials.
Price as of · Last analyzed: Mar 17, 2026Analyst Coverage for XLV: XLV does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage.
State Street Health Care Select Sector SPDR ETF (XLV) Financial Services Profile
State Street Health Care Select Sector SPDR ETF (XLV) provides investors with focused exposure to the health care sector of the S&P 500, tracking companies in pharmaceuticals, biotechnology, and healthcare services. With a market cap of $39.58 billion, it offers a strategic tool for targeted investment in the U.S. healthcare market.
What Is the Investment Thesis for XLV?
The State Street Health Care Select Sector SPDR ETF (XLV) presents a targeted investment vehicle for those seeking exposure to the U.S. healthcare sector. With a beta of 0.65, it demonstrates lower volatility compared to the broader market. The fund's focus on pharmaceuticals, biotechnology, and healthcare services positions it to benefit from long-term trends such as an aging population and advancements in medical technology. However, regulatory changes and potential drug pricing pressures represent ongoing risks. The ETF's performance is directly tied to the performance of the Health Care Select Sector Index, making it crucial to monitor the overall health and outlook of the U.S. healthcare industry.
Based on FMP financials and quantitative analysis
XLV Key Highlights
Market Cap of $39.58 billion, reflecting its significant presence in the asset management space.
- Beta of 0.65, indicating lower volatility compared to the broader market, potentially offering a more stable investment.
- Exposure to the Health Care Select Sector Index, providing targeted access to the U.S. healthcare sector.
- Holdings include companies in pharmaceuticals, biotechnology, and healthcare services, diversifying exposure within the healthcare industry.
- Managed by State Street Global Advisors, a reputable asset management firm with extensive experience in ETFs.
Who Are XLV's Competitors?
XLV is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | MoonshotScore |
|---|---|---|---|---|
| DFAC Dimensional U.S. Core Equity 2 ETF | $44.97 | +0.69% | $47.9B | — |
| DGRO iShares Core Dividend Growth ETF | $75.77 | +0.44% | $39.9B | — |
| DIA SPDR Dow Jones Industrial Average ETF Trust | $511.10 | +0.49% | $43.0B | — |
| SCHB Schwab U.S. Broad Market ETF | $29.61 | +0.75% | $44.4B | — |
| SMH VanEck Semiconductor ETF | $630.60 | +2.07% | $79.5B | — |
| BLK BlackRock, Inc. | $1059.63 | -0.44% | $164B | 49 5-pillar |
| BX Blackstone Inc. | $111.74 | -0.45% | $135B | 67 5-pillar |
| APOS Apollo Global Management, Inc. | $25.59 | -0.23% | $74.8B | 55 5-pillar |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are XLV's Key Strengths?
Targeted exposure to the U.S. healthcare sector.
- Diversification across multiple healthcare industries.
- Low expense ratio compared to actively managed funds.
- Managed by a reputable asset management firm.
What Are XLV's Weaknesses?
Concentration in a single sector, increasing risk.
- Vulnerability to regulatory changes in the healthcare industry.
- Dependence on the performance of the Health Care Select Sector Index.
- No dividend yield.
What Are the Key Risks for XLV?
Regulatory changes and drug pricing pressures impacting profitability of pharmaceutical companies.
- Economic downturns reducing healthcare spending and impacting demand for healthcare services.
- Competition from other healthcare-focused ETFs and investment vehicles.
- Dependence on the performance of the Health Care Select Sector Index, which may be affected by broader market trends.
What Are XLV's Competitive Advantages?
- Established Brand: State Street is a well-known and respected asset manager with a long history of providing investment solutions.
- Index Tracking: The ETF's performance is tied to a well-established index, providing transparency and predictability.
- Scale: The ETF's large asset base allows it to operate efficiently and offer competitive expense ratios.
What Does XLV Do?
The State Street Health Care Select Sector SPDR ETF (XLV) was created to replicate, before fees and expenses, the price and yield performance of the Health Care Select Sector Index. This index is designed to represent the healthcare sector within the broader S&P 500, offering investors a way to concentrate their investments in this specific area of the market. XLV provides exposure to a range of healthcare-related industries, including pharmaceuticals, healthcare equipment and supplies, healthcare providers and services, biotechnology, life sciences tools and services, and healthcare technology. By focusing on these specific segments, XLV allows investors to take strategic or tactical positions in the healthcare sector, offering a more targeted approach compared to broader market investments. The ETF's holdings are weighted by market capitalization, meaning that larger companies within the index have a greater impact on its overall performance. XLV is managed by State Street Global Advisors, a well-established asset management firm with a long history of providing investment solutions to a wide range of clients. The ETF is based in Boston, USA, and is designed to provide precise exposure to the U.S. healthcare market.
What Products and Services Does XLV Offer?
- Tracks the performance of the Health Care Select Sector Index.
- Provides exposure to companies in the pharmaceuticals industry.
- Offers access to companies in the biotechnology industry.
- Includes companies in the healthcare equipment and supplies industry.
- Invests in companies in the healthcare providers and services industry.
- Covers companies in the life sciences tools and services industry.
- Targets companies in the healthcare technology industry.
How Does XLV Make Money?
- The ETF generates revenue through management fees charged to investors.
- The fund's performance is directly linked to the performance of the underlying Health Care Select Sector Index.
- State Street Global Advisors manages the ETF and is responsible for its investment strategy and operations.
What Industry Does XLV Operate In?
The asset management industry is characterized by a diverse range of investment products, including ETFs, mutual funds, and hedge funds. The State Street Health Care Select Sector SPDR ETF (XLV) operates within this industry by offering a specialized investment product focused on the healthcare sector. The ETF competes with other healthcare-focused funds and broader market ETFs. The healthcare sector itself is influenced by factors such as demographic trends, technological advancements, and regulatory changes. As the population ages and demand for healthcare services increases, ETFs like XLV may benefit from increased investor interest.
Who Are XLV's Key Customers?
- Institutional investors seeking targeted exposure to the U.S. healthcare sector.
- Retail investors looking for a convenient way to invest in a diversified portfolio of healthcare stocks.
- Financial advisors using ETFs as part of their clients' investment portfolios.
Research confidence
Thin evidence — scoring coverage unknown. Treat this as a starting point, not a conclusion.
- ● Scoring coverage unknown
- ● Price is current
- ● No filing on record
- ● No analyst coverage
- ● This is an etf, not an operating company
MoonshotScore History
Recorded daily since 2026-08-23 · 41 snapshots
| 2026-08-23 | 49 |
| 2026-08-31 | 49 |
| 2026-09-08 | 49 |
| 2026-09-16 | 49 |
| 2026-09-24 | 49 |
| 2026-10-04 | 49 |
What changed?
The score has stayed at 49.
Over the same 30 days the stock moved -4.1%.
XLV Financials
Bull Case vs Bear Case
Bull Case
- Targeted exposure to the U.S. healthcare sector.
- Diversification across multiple healthcare industries.
- Low expense ratio compared to actively managed funds.
- Managed by a reputable asset management firm.
Bear Case
- Concentration in a single sector, increasing risk.
- Vulnerability to regulatory changes in the healthcare industry.
- Dependence on the performance of the Health Care Select Sector Index.
- No dividend yield.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026
XLV Latest News
-
Stocktwits Pharma Pulse: Roche Faces FDA Decision, Gene-Therapy Stocks Step Into Focus — The Week’s Biotech Watchlist
Stocktwits · Oct 5, 2026
-
Sector Update: Healthcare
MT Newswires · Oct 2, 2026
-
Sector Update: Healthcare Stocks Softer in Afternoon Trading
MT Newswires · Oct 2, 2026
-
Sector Update: Healthcare
MT Newswires · Oct 2, 2026
XLV Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for XLV.
Price Targets
Wall Street price target analysis for XLV.
XLV MoonshotScore
MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. No MoonshotScore is published for XLV; grades run from A+ (80-100) to F (below 30).
Latest News
Stocktwits Pharma Pulse: Roche Faces FDA Decision, Gene-Therapy Stocks Step Into Focus — The Week’s Biotech Watchlist
Sector Update: Healthcare
Sector Update: Healthcare Stocks Softer in Afternoon Trading
Sector Update: Healthcare
ETFs that hold XLV
Funds in our ETF coverage that list XLV among the top 10 holdings on their fund page, largest weight first. Each weight is the fund's reported holding weight as of the date in its row.
| ETF | Weight | Holdings as of |
|---|---|---|
| ETC Cabana Target Drawdown 10 ETF (TDSC) | 14.45% | |
| 3EDGE Dynamic US Equity ETF (EDGU) | 8.26% | |
| VictoryShares WestEnd Global Equity ETF (GLOW) | 7.91% | |
| Leuthold Core Exchange Traded Fund (LCR) | 4.20% |
XLV Financials Stock FAQ
What does State Street Health Care Select Sector SPDR ETF do?
The State Street Health Care Select Sector SPDR ETF (XLV) is designed to track the performance of the Health Care Select Sector Index, providing investors with targeted exposure to the U.S. healthcare sector.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
MoonshotScore is not published for this security.
Data provided for informational purposes only.
- The ETF's performance is dependent on the performance of the Health Care Select Sector Index.
- Regulatory changes in the healthcare industry can significantly impact the ETF's performance.